Florian Vogel
Tracked across 2 events · 13 articles · First seen Jun 16, 2026 · Last active Jun 25, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: As CEO of Innovative Molecules, Florian Vogel announced the advancement of the EBV antiviral program, highlighting the company's commitment to innovative therapeutic approaches for serious viral diseases. His statements reinforce the strategic importance of this development.
Jun 16, 2026 · 6 articles
Tech
Impact: Florian Vogel, CEO of Innovative Molecules, expressed the significance of this milestone for the company's maturation and its goal to deliver transformative therapy.
Jun 25, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Florian Vogel live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard